Back to Journals » Drug Design, Development and Therapy » Volume 15

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

Total article views   HTML views PDF downloads Totals
5,981 Dovepress* 5,167+ 640 5,807
PubMed Central* 814 280 1,094
Totals 5,981 920 6,901
*Since 27 January 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar